Mason Street Advisors, LLC Dexcom Inc Transaction History

Mason Street Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$84.79 - $104.74 $1.12 Million - $1.39 Million	-13,247 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$78.0 - $104.5 $15,600 - $20,900	-200 Reduced 1.49%	13,247 $4.9 Million
Q3 2020 Nov 13, 2020	BUY	$95.51 - $112.95 $25,787 - $30,496	270 Added 2.05%	13,447 $5.54 Million
Q2 2020 Aug 14, 2020	BUY	$62.68 - $105.34 $825,934 - $1.39 Million	13,177 New	13,177 $5.34 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $28.8B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Mason Street Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Mason Street Advisors, LLC with notifications on news.